Products & Services · Discount rate

HLD-0117 — Discount rate

Analysis

StatementSegment
CategoryCapital Allocation
SignalLower is better
VolatilityStable
First reportedQ4 2025
Last reportedQ4 2025

How to read this metric

An increase in the discount rate suggests higher perceived risk or a higher cost of capital for the project, which lowers the asset's present value. A decrease indicates improved risk assessment or lower capital costs, increasing the asset's valuation.

Detailed definition

The discount rate applied to the projected future cash flows of the HLD-0117 asset to determine its present value. This...

Peer comparison

Comparable to weighted average cost of capital (WACC) or risk-adjusted hurdle rates used by pharmaceutical peers for specific clinical-stage pipeline assets.

Metric ID: jnj_segment_hld_0117_discount_rate

Historical Data

1 periods
 Q4 '25
Value0.2

Frequently Asked Questions

What is Johnson & Johnson's hld-0117 — discount rate?
Johnson & Johnson (JNJ) reported hld-0117 — discount rate of $0.18 in Q4 2025.
What does hld-0117 — discount rate mean?
The interest rate used to calculate the current value of future earnings expected from the HLD-0117 project.